Erythrocyte fatty acid profiles were determined by gas liquid chromatography in 23 patients with benign eye dis eases and 19 patients with ocular melanoma. The erythro cyte SI was lower in patients with ocular melanoma (mean 0.65, range 0.30-1.04) then in patients with benign eye disease (mean 1.01, range 0.84-1.24) (P < 0.001). This Sl may be useful as a means of differentiating between patients with benign and malignant ocular disease.
Melanoma is the most common primary intraocular malignancy and has a high incidence of metastases, especially to the liver. 4 Approximately half of the patients will die from the disease within 10-15 years of enuclea tion,5,6 and late metastases are not uncommon. 6 The median survival following diagnosis of hepatic metastases is two to four months.7,s Despite diagnostic and thera peutic advances the incidence and mortality rates of uveal melanoma have been shown to be fairly stable over the last several decades.9,lo There is a need for better indices which could provide guidance for the diagnosis, assessment and management of patients with ocular melanoma in the hope of improving their prognosis. The stearic to oleic acid ratio (Saturation Index, SI) is known to be reduced in the membranes of some types of neoplastic cells.II,12 It has been shown that the erythrocyte SI is low in patients with various solid tumoursl3 and in patients with chronic leukaemia 14 when compared to normal healthy subjects, It is believed that the SI is altered by factors secreted by the tumour into the systemic cir culation. 16 In other tumours like hepatomal2 the erythro cyte SI is not reduced. It has been shown that the erythrocyte SI is lower in patients with recurrent cancer compared to those with no evidence of recurrence13, 15 It has therefore been suggested that the SI could be a useful marker for the diagnosis and postoperative monitoring of patients with some malignant tumours. However, it has recently been demonstrated that although erythrocyte SI is lower in patients with primary and recurrent colorectal cancer compared to controls and patients with inflamma tory bowel disease or benign colonic polyps, it was not helpful in the postoperative follow-up of these patients as it did not correlate with their clinical progress.17 Some workers, 1 8-2 0 have not been able to demonstrate a decrease in the erythrocyte SI of cancer patients but it is not poss ible to compare the results of various groups since each used a different method for lipid extraction,
The aim of this study is to investigate whether the eryth rocyte SI is reduced in patients with ocular melanoma.
PATIENTS AND METHODS
Nineteen patients with ocular melanoma were studied (M:F = 8: 11; mean age 58 years, range 21-71 years). There were 16 patients with choroidal melanoma, two patients with melanoma of the iris and one patient with recurrent conjunctival melanoma. In the patients with choroidal melanoma, eight patients were treated by enucleation, five by radioactive plaques and the remaining three were being observed without any treatment. The patient with con junctival melanoma underwent excision of local recur rence. One patient with melanoma of the iris had the lesion excised and remains under follow-up while the other patient developed multiple metastases and subsequently died. None of the patients included in this study was jaun diced at the time of testing.
The control group consisted of patients with benign dis eases and were matched for age and sex with the melan oma group (n = 23; M:F 12:11; mean age 57 years, range 24-76 years). These consisted of 19 patients with cataract, two patients with uveitis and two patients with ocular hypertension.
Five millilitres of venous blood were collected from each patient in an EDTA bottle and centrifuged at 1,500 rpm for five minutes to separate the erythrocytes. The plasma was discarded and the erythrocytes were washed three times with phosphate buffered saline (PBS). Fol lowing this, the erythrocytes were diluted 1:5 with PBS. This was performed within three hours of venepuncture. An identical procedure was followed for all melanoma and control samples in order to avoid the potential aber rations that could result from variable delays in the pro cessing. The analyses were undertaken by the same technician who was unaware of the diagnosis at the time of analysis. The lipids were extracted from the erythrocytes by the method described by Folch et at. 21 The erythrocyte suspension (0.1 ml) was added to 0.5 ml of methanol and mixed for 45 seconds. Following this, 1.4 ml of freshly prepared methanol:chloroform (2: 19) was added to the solution, which was mixed again. Methanol (0.42 ml) was added and the solution was again mixed and then cen trifuged at 1,000 rmp for 10 minutes. After this, as much of the upper phase as possible was extracted into a new tube. Chloroform (0.7 ml) and water (0.6 ml) were added and the solution was mixed again following which it was centrifuged at 1,000 rpm for 10 minutes. The upper phase was then removed and discarded three times, each time washing with 1.0 ml of pure upper phase solvents (chlo roform:methanol:distilled water at a ratio of 3:48:47). Finally, methanol (0.2 ml) was added to clear the solution, which was then dried down under nitrogen on a sample concentrator.
The fatty acids were then extracted from the lipids by the method described by MacGee et at. 19 The lipids were saponified by the additin of 15% methanolic potassium hydroxide (1.0 ml) and the solution was mixed. Each specimen was then incubated at 65°C for 15 minutes, shaken by hand and re-incubated at 65°C for a further 15 minutes, after which it was allowed to cool. Distilled water (1.0 ml) was added, followed by 4N hydrochloric acid (0.6 ml) and the solution was mixed again. The hydrochloric acid liberated free fatty acids from the pot assium salts of the fatty acids, which were then extracted in 2.0 ml of benzene, following which the solution was mixed and then centrifuged at 1,000 rpm for ten minutes. The bottom phase was then discarded.
Finally, the free fatty acids were methylated by the method described by Morrison and Smith.2 0 Boron trichlo ride in methanol (1.0 ml) was added to the solution, fol lowing which it was mixed and then incubated at 100°C 417 for ten minutes. After allowing the solution to cool to room temperature, distilled water (2.0 ml) was added. The solution was mixed again and then centrifuged at 1,000 rpm for ten minutes. Following this, some of the upper (organic) phase was dried down under nitrogen, removed into a capsule and then dried down completely under nitrogen. It was then re-dissolved in six drops of trimeth ylpentane and stored at -20°C until analysed by gas liquid chromatography.
The fatty acid methyl esters were analysed by temper ature-programmed (160-260°C at 4°C/min) gas liquid chromatography, using a 2m x 2mm internal diameter glass column packed with 3% SP-2310/2% SP-2300 on 100/120 mesh chromo sorb W (Supelco Inc.). This gives a computer print out, which gives a completely objective means of measuring the percentage of each fatty acid pres ent. The various peaks represent different fatty acids. The computer was programmed to measure the area under each peak. The percentage of each fatty acid present was determined from the percentage of each peak area com pared to the total peak area. The ratio of stearic to oleic acid was taken from the chromatogram and expressed as the saturation index (SI). Statistical analysis was by an unpaired t test. Ethical committee approval for the study was obtained and the nature of the study was fully explained to the patients concerned.
RESULTS
The mean erythrocyte SI was 0.65 (range 0.30-1.04) in the melanoma group compared to 1.01 (range 0.84-1.24) in the control group (Fig. 1) (P < 0.001) . The erythrocyte SI in the patient with iris melanoma and multiple metastases (0.36) was near the lower end of the range. This patient was found to have multiple metastses within a few months
Control group Ocular Melanoma of diagnosis and died ten months later. Two patients, who at the time of enucleation had an erythrocyte SI of 0.60 and 0.62 respectively, were assessed again six months later and their erythrocyte SI had increased to 0.87 and 0.94 respectively. U sing the saturation index as a means of differentiating between patients with ocular melanoma and normal sub jects, the sensitivity is 84.2% and the specificity is 91.3% when 0.92 is taken as a cut off point (which is equal to the mean minus one standard deviation: 0.09). The positive predictive value is 88.9% and the negative predictive value is 87.5%
DISCUSSION
The demonstration of a low erythrocyte stearic to oleic acid ratio (SI) in patients with ocular melanoma compared to patients with benign eye diseases suggests that this tumour does, in this aspect, behave similarly to other neo plasms which reduce the SI3 as opposed to those which do notI2 Despite their small mass ocular melanomas are asso ciated with a widespread effect on the red blood cells which could be used as a tumour marker. It has been pos tulated that this phenomenon might be caused by the release of a desaturation producing factor by the tumour which acts as a catalyst for Delta-9-desaturase enzymes, or that the tumour could be releasing growth fac tors which affect the red blood cells progenitors.I3 The erthyrocyte SI could be used to differentiate between benign and malignant choroidal lesions. If the SI reflects the mitotic activity of the tumour it could help to assess its malignant potential. It could also be of value in monitor ing the progress of the disease in patients who are being reviewed or have had treatment such as enucleation or radiotherapy. If the SI is checked at regular intervals it might signal a recurrence or a metastasis before it becomes clinically obvious.
There are some limitations to the use of the SI measure ment as a clinical tool. The procedure is complex and requires gas liquid chromatography as well as a specially trained technician. Reduction in the erythrocyte SI occurs in patients with various other tumours and therefore this marker may not help to differentiate between ocular mel anoma and choroidal metastases. The erythrocyte SI is also reduced in diabetics26 and in jaundiced patients27 probably because of altered lipid metabolism.
The usefulness of this tumour marker will be verified and its predictive value further assessed by long-term review of patients in whom the erythrocyte SI is known.
